Summarized by Masters of Longevity from Longevity Technology.
Digbi Health reported 18.4% average weight loss with tirzepatide plus its program.

Key Takeaways
- Digbi Health reports 18.4% mean weight loss with program.
- Reported results compare favorably to published tirzepatide cohorts.
- These observational comparisons have not established causality yet.



